PT Millennium Pharmacon International Tbk (IDX:SDPC)

IDX:SDPC Revenue

PT Millennium Pharmacon International Tbk had revenue of 1.11T IDR in the quarter ending June 30, 2026, with 15.66% growth. This brings the company's total for the last twelve months to 4.30T, up 9.67% year-over-year. In the year 2025, PT Millennium Pharmacon International Tbk had annual revenue of 4.11T with 4.93% growth. That makes PT Millennium Pharmacon International Tbk the 16,095th largest company in the world by revenue and 216th in Indonesia.

• Revenue (ttm): 4.30T
• Revenue Growth: +9.67%
• P/S Ratio: 0.06
• Revenue / Employee: 3.67B
• Employees: 1,197
• Market Cap: 252.25B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Prescription Medicine 2.89T 70.3%
• Medical Devices 1.08T 26.2%
• Non-Prescription Medicine 143.45B 3.5%
• Others 382.50M 0.0%

Fiscal year ended Dec 31, 2025 See the full IDX:SDPC breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.11T	192.95B	4.93%
Dec 31, 2024	3.92T	553.35B	16.45%
Dec 31, 2023	3.36T	162.68B	5.08%
Dec 31, 2022	3.20T	211.98B	7.09%
Dec 31, 2021	2.99T	345.22B	13.06%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error